Treating Lid Wiper Epitheliopathy

Inclusion Criteria: * Adults ≥18 years of age * best corrected visual acuity (BCVA) of 20/100 or better * who have symptomatic DED will be recruited (SPEED ≥6) * Subjects will also be required to have a LWE score of 1.0 or greater to be included in the study. * Subjects will be required to discontinue contact lens wear throughout the study. Exclusion Criteria: * known systemic health conditions that are known to alter tear film physiology (e.g., primary and secondary Sjögren's syndrome), * have a history of ocular surgery within the past 12 months, have a history of severe ocular trauma, active ocular infection or inflammation, * are currently using Accutane or ocular medications, or if they are pregnant or breast feeding. * Artificial tear use will be discontinued at least one week prior to enrollment. Subjects with a condition or in a situation, which in the examiner's opinion, may put the subject at significant risk, may confound the study results, or may significantly interfere with their participation in the study will be excluded. * Subjects that have had a physical meibomian gland treatment withing 1 month of enrollment (iLux, Lipiflow, etc.) will be excluded. * Subjects will not be allowed to use any eye drops beyond their assignment during the study.